KALA BIO
KALA
13 hedge funds and large institutions have $3.68M invested in KALA BIO in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
40% more capital inflows, than outflows
Capital inflows: $180K | Capital outflows: $129K
18% more funds holding
Funds holding: 11 → 13 (+2)
0.68% less ownership
Funds ownership: 20.22% → 19.55% (-0.68%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$95.5K |
| 2 |
Tower Research Capital (TRC)
New York
|
+$31.8K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$21.2K |
| 4 |
BlackRock
New York
|
+$10.6K |
| 5 |
Knights of Columbus Asset Advisors
New Haven,
Connecticut
|
+$10.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$108K |
| 2 |
Millennium Management
New York
|
-$21.2K |
| 3 |
Parkside Financial Bank & Trust
Saint Louis,
Missouri
|
-$339 |
| 4 |
Bank of New Hampshire
Laconia,
New Hampshire
|
-$9 |
KALA Hedge Fund Activity: Q4 2023 in Review
13 of the 6,880 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2023, worth a combined $3.68M — down 19% from $4.57M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new KALA positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $95.5K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $108K sold.
- 13 institutional investors held KALA BIO (KALA) as of Q4 2023, up from 11 in Q3 2023.
- Funds reported $3.68M of KALA BIO stock for Q4 2023, down 19% quarter-over-quarter.
- 3 funds opened new KALA BIO positions in Q4 2023 and 1 closed out, a net change of +2 holders.
- The largest KALA BIO buyer in Q4 2023 was Renaissance Technologies, an estimated $95.5K added.
- The largest KALA BIO seller in Q4 2023 was Dimensional Fund Advisors, an estimated $108K sold.
Based on aggregated 13F filings for Q4 2023.